ProQR Therapeutics N.V.
PRQR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,006 | -$12,179 | -$10,079 | -$9,305 |
| Dep. & Amort. | $671 | $675 | $678 | $671 |
| Deferred Tax | $0 | $18 | $0 | $0 |
| Stock-Based Comp. | $0 | $909 | $758 | $568 |
| Change in WC | -$3,074 | -$1,178 | -$6,721 | -$543 |
| Other Non-Cash | $1,174 | $354 | -$434 | -$739 |
| Operating Cash Flow | -$12,235 | -$11,401 | -$15,798 | -$9,348 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$169 | -$101 | -$224 | -$133 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$2,655 |
| Investing Cash Flow | -$169 | -$101 | -$224 | -$2,788 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$444 | -$293 | -$567 | -$253 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $67 | $71,683 |
| Financing Cash Flow | -$444 | -$293 | -$500 | $71,430 |
| Forex Effect | -$34 | -$854 | -$472 | $713 |
| Net Chg. in Cash | -$12,882 | -$12,649 | -$16,994 | $60,007 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $119,765 | $132,414 | $149,408 | $89,401 |
| End Cash | $106,883 | $119,765 | $132,414 | $149,408 |
| Free Cash Flow | -$12,404 | -$11,502 | -$16,022 | -$9,481 |